Press-Needle Therapy Combined with Sensory Integration Training Shows Comparable Efficacy to Medication for Children with Tic Disorders

This prospective three-arm randomised controlled trial investigated whether press-needle therapy combined with sensory integration training could offer a safe, non-pharmacological option for managing mild to moderate tic disorders in children aged six to twelve years. A total of 162 children were divided equally into three groups: one receiving press-needle therapy plus sensory integration training, one receiving sensory integration training alone, and one receiving the standard pharmaceutical drug tiapride hydrochloride. The trial ran for twelve weeks, followed by a further twelve-week follow-up period.

All three groups demonstrated statistically significant improvements in tic severity scores and traditional Chinese medicine syndrome scores by weeks six and twelve. Notably, the combination of press-needle therapy and sensory integration training produced between-group differences that were statistically significant at week twelve and at the follow-up assessment, outperforming sensory integration training alone. Overall clinical response rates were high across all groups, with no statistically significant difference between them. Crucially, no adverse events were recorded in the press-needle therapy plus sensory integration training group, compared with one case in the sensory integration training group and five cases among those taking tiapride hydrochloride.

The results indicate that press-needle therapy enhances the benefits of sensory integration training and achieves tic reduction broadly comparable to first-line drug treatment, with a markedly better safety profile.

Conclusion: Press-needle therapy combined with sensory integration training appears to be a safe and effective non-pharmacological alternative for children with mild to moderate tic disorders, offering results comparable to standard medication without associated side effects.

Source: Ge SN, Hu WL, Wang CL and colleagues. Medicine (2026). View on PubMed (PMID 42432962) · doi:10.1097/MD.0000000000049703

Acupuncture Times Logo

Hi there!

Sign up to receive the latest research in acupuncture, cupping, moxibustion, Chinese herbal medicine and more, once a week.

About Attilio

Doctor of Chinese medicine, acupuncture expert and author of My Fertility Guide and My Pregnancy Guide.

Check Also

PubMed research

Weishen Decoction Shows Promising Safety and Symptom Relief in Elderly Osteoporosis Patients with Kidney-Yang Deficiency

Research summary (Traditional Chinese Medicine): Safety and Efficacy of Weishen Decoction in Elderly Patients with Osteoporosis and Kidney-Yang Deficiency: A Randomized Trial. - Journal of visualized experiments : JoVE, 2026.